Stewart Abbot
2015
In 2015, Stewart Abbot earned a total compensation of $1M as Chief Development Officer at Fate Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $20,806 |
|---|---|
| Option Awards | $567,182 |
| Salary | $145,260 |
| Stock Awards | $206,803 |
| Other | $80,000 |
| Total | $1,020,051 |
Abbot received $567.2K in option awards, accounting for 56% of the total pay in 2015.
Abbot also received $20.8K in non-equity incentive plan, $145.3K in salary, $206.8K in stock awards and $80K in other compensation.
Rankings
In 2015, Stewart Abbot's compensation ranked 7,847th out of 13,638 executives tracked by ExecPay. In other words, Abbot earned more than 42.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,847 out of 13,638 | 43rd |
Division Manufacturing | 2,974 out of 5,187 | 43rd |
Major group Chemicals And Allied Products | 1,076 out of 1,857 | 42nd |
Industry group Drugs | 869 out of 1,531 | 43rd |
Industry Biological Products, Except Diagnostic Substances | 148 out of 260 | 43rd |
Source: SEC filing on March 22, 2017.
Abbot's colleagues
We found three more compensation records of executives who worked with Stewart Abbot at Fate Therapeutics in 2015.